The European Union has reached a deal with U.S. biotech firm Moderna for the supply of up to 160 million doses of its COVID-19 vaccine candidate, the president of the European Commission said on Tuesday.
The deal will be formally approved by the EU executive on Wednesday, Ursula von der Leyen said.